RadNet Inc. (OQ:RDNT)

Business Focus: Medical & Diagnostic Laboratories

Sector:  Healthcare Industry:  Healthcare Facilities & Services
 
See Regulatory Filings on SEC
Company Contact
Address: 1510 Cotner Ave
LOS ANGELES CA 90025-3303
Tel: N/A
Website: https://www.radnet.com
IR: See website
<
Key People
Howard G. Berger
Chairman of the Board, President, Chief Executive Officer 		Stephen M. Forthuber
President and Chief Operating Officer '€“ Eastern Operations 		Norman R. Hames
President, Chief Operating Officer-Western Operations, Corporate Secretary
Mark D. Stolper
Chief Financial Officer, Executive Vice President 		Mital Patel
Executive Vice President - Finance and Analysis 		Michael N. Murdock
Executive Vice President, Chief Development Officer
John V. Crues
Vice President, Medical Director, Director 		   
Business Overview
RadNet, Inc. is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. As of December 31, 2016, the Company operated directly or indirectly through joint ventures, 305 centers located in California, Delaware, Florida, Maryland, New Jersey, New York and Rhode Island. Its centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Its services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. As of December 31, 2016, the Company had in operation 257 MRI systems, 157 CT systems, 47 PET or combination PET/CT systems, 48 nuclear medicine systems, 479 X-ray systems, 279 mammography systems, 551 ultrasound systems and 104 fluoroscopy systems.
Financial Overview
For the fiscal year ended 31 December 2018, RadNet Inc. revenues increased 6% to $975.1M. Net income before extraordinary items increased from $13.6M to $32.2M. Revenues reflect Net Revenue increase of 1% to $868.7M. Net income benefited from (Gain) loss on sale and disposal of equi decrease from $1.1M (expense) to $2.1M (income), Other (income) expenses increase from $8K to $181K (income).
Employees: 5,706 as of Dec 31, 2018
Reporting Currency: U.S. Dollars
Enterprise value: $1,303M as of Dec 31, 2018
Annual revenue (TTM): $975.15M as of Dec 31, 2018
EBITDA (TTM): $107.60M as of Dec 31, 2018
Net annual income (TTM): $32.24M as of Dec 31, 2018
Free cash flow (TTM): -$28.62M as of Dec 31, 2018
Net Debt Last Fiscal Year: $661.89M as of Dec 31, 2018
Shares outstanding: 50,071,479 as of Mar 12, 2019
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization